Featured # Editorials | 3 years ago

Three Nasdaq Stocks To Watch Under $10

Three Nasdaq Stocks To Watch Under $10

Excitement surrounding the events leading up to troubles with North Korea. The stock market is on high alert after President Trump made comment to what U.S. President Harry S. Truman said before ordering the use of force on a nuclear level against Japan.

In light of this, the broader markets took a turn to the red heading into the lunch hour and the CBOE Volatility index, which maps market fear, spiked. Despite this occurring, there were stocks that went against the general down trend; many in a big way. Several stocks trading under ten dollars per share have been bucking a bull trend for the majority of the month as well.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for infectious diseases and immune system disorders in the United States and internationally. In the past 20 days, the company has seen a 38.4% increase in its share price. Today, the New Haven, Conn.-based firm reported second-quarter results and discussed interim results from a Phase 2 study of ACH-4471 for patients with untreated paroxysmal nocturnal hemoglobinuria.

Xtant Medical Holdings, Inc. (XTNT) also made the list on Wednesday. The medical holding company has seen its share price climb since August 3rd when the stock was trading at roughly $0.70. August 9 trading activity saw the stock hit highs of $1.51. The company’s announcement that the U.S. Food and Drug Administration has cleared a product line extensions for the Calix-C family of cervical interbody cages, has drawn attention to the company.

“This new FDA clearance allows Xtant Medical to leverage the clinical effectiveness of our established allograft product offerings for use with our now expanded line of interbody devices in cervical discectomy and fusion procedures” stated Dr. Gregory Juda, CSO and GM of Xtant Medical. “We expect that the use of these products as a combined spinal fusion solution will result in positive patient outcomes.”

Digiliti Money, Inc. (DGLT) has seen activity pick up ruing the second half of the trading day. After opening the day at $0.36, the stock has managed to hit a high of $0.68 before the 1 o’clock hour. On August 4th the company announced that Jeffrey Mack had resigned from the Board of Directors and from his position as President and Chief Executive Officer. Interim CEO Bryan Meier stated that, “In light of the recent management change and our preliminary Q2 results, we will be evaluating the Company’s go forward strategy. Our near-term focus will be on our core products, growing our existing customers, and becoming more selective about the opportunities we pursue.”

Prior to this, shares of Digiliti Money were trading above $2 per share.


Post a Comment

Your email address will not be published. Required fields are marked *